Pure Global

Monoclonal Anti Sera-A - India CDSCO Medical Device Registration

Monoclonal Anti Sera-A is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000085_7b8250cd5cacd203d00496ab056d4417_7fd1ccb1f98fb82fb91085cf1a0df947. This device is marketed under the brand name Rapid Plasma Reagin. The license holder is Voxtur Bio Ltd, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, West Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Monoclonal Anti Sera-A
UID: MFG/IVD/2022/000085_7b8250cd5cacd203d00496ab056d4417_7fd1ccb1f98fb82fb91085cf1a0df947

Brand Name

Rapid Plasma Reagin

License Holder

Voxtur Bio Ltd

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, West Zone

Product Information

The Anti-A test is used for rapid visual agglutination test for the qualitative detection of presence of A antigens in human Whole blood samples

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing